Back
Matinas BioPharma Holdings Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
MTNB
Matinas BioPharma Holdings
Last Price:
$0.57
Seasonality Move:
-2.23%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing buying pressure, which is a positive indicator for future bullish movement.
Matinas BioPharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.57 | Sell |
| 20-day SMA: | 0.56 | Buy |
| 50-day SMA: | 0.58 | Sell |
| 200-day SMA: | 3.29 | Sell |
| 8-day EMA: | 0.57 | Sell |
| 20-day EMA: | 0.57 | Sell |
| 50-day EMA: | 0.65 | Sell |
| 200-day EMA: | 3.31 | Sell |
Matinas BioPharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 48.99 | Sell |
| Chaikin Money Flow: | 27502 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.55 - 0.59) | Sell |
| Bollinger Bands (100): | (0.37 - 0.89) | Sell |
Matinas BioPharma Holdings Technical Analysis
| Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Matinas BioPharma Holdings Stock
Is Matinas BioPharma Holdings Stock a Buy?
-
Matinas BioPharma Holdings share price is 0.57 while MTNB 8-day simple moving average is 0.57, which is a Sell signal.
-
The stock price of MTNB is 0.57 while Matinas BioPharma Holdings 20-day SMA is 0.56, which makes it a Buy.
-
Matinas BioPharma Holdings 50-day simple moving average is 0.58 while MTNB share price is 0.57, making it a Sell technically.
-
MTNB stock price is 0.57 and Matinas BioPharma Holdings 200-day simple moving average is 3.29, creating a Sell signal.
MTNB Technical Analysis vs Fundamental Analysis
Sell
33
Matinas BioPharma Holdings (MTNB)
is a Sell
Is Matinas BioPharma Holdings a Buy or a Sell?
-
Matinas BioPharma Holdings stock is rated a SellThe current Matinas BioPharma Holdings [MTNB] share price is $0.57. The Score for MTNB is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Matinas BioPharma Holdings Stock Info
Market Cap:
2.9M
Price in USD:
0.57
Share Volume:
34.4K
Matinas BioPharma Holdings 52-Week Range
52-Week High:
18.49
52-Week Low:
0.48
Sell
33
Matinas BioPharma Holdings (MTNB)
is a Sell
Matinas BioPharma Holdings Share Price Forecast
-
What is the Matinas BioPharma Holdings stock price today?The Matinas BioPharma Holdings stock price is 0.57 USD today.
-
Will MTNB stock go up or go down?Matinas BioPharma Holdings> share price is forecast to RISE/FALL based on technical indicators
-
Is Matinas BioPharma Holdings overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Matinas BioPharma Holdings is overvalued.
Is Matinas BioPharma Holdings Stock a Buy?
-
Matinas BioPharma Holdings share price is 0.57 while MTNB 8-day exponential moving average is 0.57, which is a Sell signal.
-
The stock price of MTNB is 0.57 while Matinas BioPharma Holdings 20-day EMA is 0.57, which makes it a Sell.
-
Matinas BioPharma Holdings 50-day exponential moving average is 0.65 while MTNB share price is 0.57, making it a Sell technically.
-
MTNB stock price is 0.57 and Matinas BioPharma Holdings 200-day simple moving average is 3.31, creating a Sell signal.
Fundamental Analysis of Matinas BioPharma Holdings
Is Matinas BioPharma Holdings a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.56 per share, and a decrease next year of $2.50 per share.
Technical Analysis of Matinas BioPharma Holdings
Should I short Matinas BioPharma Holdings stock?
-
MTNB Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Matinas BioPharma Holdings is a Sell
-
Matinas BioPharma Holdings Relative Strength Index (RSI) is 48.99, which suggest Matinas BioPharma Holdings is oversold
-
The Bollinger Bands (25) for Matinas BioPharma Holdings is (0.55 - 0.59), which suggest Matinas BioPharma Holdings is a Sell
-
The Bollinger Bands (100) for Matinas BioPharma Holdings is (0.37 - 0.89), which suggest Matinas BioPharma Holdings is a Sell
* Matinas BioPharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.